ALOX5 and neoplasm: In TAMs, 5-LO is downregulated through MerTK (a receptor tyrosine kinase) after the recognition of apoptotic cancer cells, and activation of its transcriptional repression through c-Myb.5-LO expression deficiency leads to a reduced ability of TAMs to recruit T cells and exert anti-tumor effects.